260 related articles for article (PubMed ID: 26863991)
1. L-arginine promotes gut hormone release and reduces food intake in rodents.
Alamshah A; McGavigan AK; Spreckley E; Kinsey-Jones JS; Amin A; Tough IR; O'Hara HC; Moolla A; Banks K; France R; Hyberg G; Norton M; Cheong W; Lehmann A; Bloom SR; Cox HM; Murphy KG
Diabetes Obes Metab; 2016 May; 18(5):508-18. PubMed ID: 26863991
[TBL] [Abstract][Full Text] [Related]
2. l-phenylalanine modulates gut hormone release and glucose tolerance, and suppresses food intake through the calcium-sensing receptor in rodents.
Alamshah A; Spreckley E; Norton M; Kinsey-Jones JS; Amin A; Ramgulam A; Cao Y; Johnson R; Saleh K; Akalestou E; Malik Z; Gonzalez-Abuin N; Jomard A; Amarsi R; Moolla A; Sargent PR; Gray GW; Bloom SR; Murphy KG
Int J Obes (Lond); 2017 Nov; 41(11):1693-1701. PubMed ID: 28792489
[TBL] [Abstract][Full Text] [Related]
3. Selective release of gastrointestinal hormones induced by an orally active GPR39 agonist.
Grunddal KV; Diep TA; Petersen N; Tough IR; Skov LJ; Liu L; Buijink JA; Mende F; Jin C; Jepsen SL; Sørensen LME; Achiam MP; Strandby RB; Bach A; Hartmann B; Frimurer TM; Hjorth SA; Bouvier M; Cox H; Holst B
Mol Metab; 2021 Jul; 49():101207. PubMed ID: 33711555
[TBL] [Abstract][Full Text] [Related]
4. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
Baggio LL; Huang Q; Brown TJ; Drucker DJ
Gastroenterology; 2004 Aug; 127(2):546-58. PubMed ID: 15300587
[TBL] [Abstract][Full Text] [Related]
5. L-Arginine Increases Postprandial Circulating GLP-1 and PYY Levels in Humans.
Amin A; Neophytou C; Thein S; Martin NM; Alamshah A; Spreckley E; Bloom SR; Murphy KG
Obesity (Silver Spring); 2018 Nov; 26(11):1721-1726. PubMed ID: 30358156
[TBL] [Abstract][Full Text] [Related]
6. The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents.
Psichas A; Sleeth ML; Murphy KG; Brooks L; Bewick GA; Hanyaloglu AC; Ghatei MA; Bloom SR; Frost G
Int J Obes (Lond); 2015 Mar; 39(3):424-9. PubMed ID: 25109781
[TBL] [Abstract][Full Text] [Related]
7. Endogenous PYY and GLP-1 mediate l-glutamine responses in intestinal mucosa.
Joshi S; Tough IR; Cox HM
Br J Pharmacol; 2013 Nov; 170(5):1092-101. PubMed ID: 23992397
[TBL] [Abstract][Full Text] [Related]
8. Ghrelin suppresses cholecystokinin (CCK), peptide YY (PYY) and glucagon-like peptide-1 (GLP-1) in the intestine, and attenuates the anorectic effects of CCK, PYY and GLP-1 in goldfish (Carassius auratus).
Blanco AM; Bertucci JI; Valenciano AI; Delgado MJ; Unniappan S
Horm Behav; 2017 Jul; 93():62-71. PubMed ID: 28506816
[TBL] [Abstract][Full Text] [Related]
9. Gut hormones as peripheral anti obesity targets.
Small CJ; Bloom SR
Curr Drug Targets CNS Neurol Disord; 2004 Oct; 3(5):379-88. PubMed ID: 15544446
[TBL] [Abstract][Full Text] [Related]
10. Role of capsaicin-sensitive peripheral sensory neurons in anorexic responses to intravenous infusions of cholecystokinin, peptide YY-(3-36), and glucagon-like peptide-1 in rats.
Reidelberger R; Haver A; Anders K; Apenteng B
Am J Physiol Endocrinol Metab; 2014 Oct; 307(8):E619-29. PubMed ID: 25117406
[TBL] [Abstract][Full Text] [Related]
11. Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.
Neary NM; Small CJ; Druce MR; Park AJ; Ellis SM; Semjonous NM; Dakin CL; Filipsson K; Wang F; Kent AS; Frost GS; Ghatei MA; Bloom SR
Endocrinology; 2005 Dec; 146(12):5120-7. PubMed ID: 16150917
[TBL] [Abstract][Full Text] [Related]
12. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
Svane MS; Jørgensen NB; Bojsen-Møller KN; Dirksen C; Nielsen S; Kristiansen VB; Toräng S; Wewer Albrechtsen NJ; Rehfeld JF; Hartmann B; Madsbad S; Holst JJ
Int J Obes (Lond); 2016 Nov; 40(11):1699-1706. PubMed ID: 27434221
[TBL] [Abstract][Full Text] [Related]
13. Effects of dipeptidyl peptidase IV inhibition on glycemic, gut hormone, triglyceride, energy expenditure, and energy intake responses to fat in healthy males.
Heruc GA; Horowitz M; Deacon CF; Feinle-Bisset C; Rayner CK; Luscombe-Marsh N; Little TJ
Am J Physiol Endocrinol Metab; 2014 Nov; 307(9):E830-7. PubMed ID: 25231186
[TBL] [Abstract][Full Text] [Related]
14. Systemic bile acid sensing by G protein-coupled bile acid receptor 1 (GPBAR1) promotes PYY and GLP-1 release.
Ullmer C; Alvarez Sanchez R; Sprecher U; Raab S; Mattei P; Dehmlow H; Sewing S; Iglesias A; Beauchamp J; Conde-Knape K
Br J Pharmacol; 2013 Jun; 169(3):671-84. PubMed ID: 23488746
[TBL] [Abstract][Full Text] [Related]
15. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters.
le Roux CW; Aylwin SJ; Batterham RL; Borg CM; Coyle F; Prasad V; Shurey S; Ghatei MA; Patel AG; Bloom SR
Ann Surg; 2006 Jan; 243(1):108-14. PubMed ID: 16371744
[TBL] [Abstract][Full Text] [Related]
16. Effects of resistant starch, a non-digestible fermentable fiber, on reducing body fat.
Keenan MJ; Zhou J; McCutcheon KL; Raggio AM; Bateman HG; Todd E; Jones CK; Tulley RT; Melton S; Martin RJ; Hegsted M
Obesity (Silver Spring); 2006 Sep; 14(9):1523-34. PubMed ID: 17030963
[TBL] [Abstract][Full Text] [Related]
17. Neurotensin Is Coexpressed, Coreleased, and Acts Together With GLP-1 and PYY in Enteroendocrine Control of Metabolism.
Grunddal KV; Ratner CF; Svendsen B; Sommer F; Engelstoft MS; Madsen AN; Pedersen J; Nøhr MK; Egerod KL; Nawrocki AR; Kowalski T; Howard AD; Poulsen SS; Offermanns S; Bäckhed F; Holst JJ; Holst B; Schwartz TW
Endocrinology; 2016 Jan; 157(1):176-94. PubMed ID: 26469136
[TBL] [Abstract][Full Text] [Related]
18. Selective FFA2 Agonism Appears to Act via Intestinal PYY to Reduce Transit and Food Intake but Does Not Improve Glucose Tolerance in Mouse Models.
Forbes S; Stafford S; Coope G; Heffron H; Real K; Newman R; Davenport R; Barnes M; Grosse J; Cox H
Diabetes; 2015 Nov; 64(11):3763-71. PubMed ID: 26239054
[TBL] [Abstract][Full Text] [Related]
19. The common hepatic branch of the vagus is not required to mediate the glycemic and food intake suppressive effects of glucagon-like-peptide-1.
Hayes MR; Kanoski SE; De Jonghe BC; Leichner TM; Alhadeff AL; Fortin SM; Arnold M; Langhans W; Grill HJ
Am J Physiol Regul Integr Comp Physiol; 2011 Nov; 301(5):R1479-85. PubMed ID: 21849636
[TBL] [Abstract][Full Text] [Related]
20. A Gut-Intrinsic Melanocortin Signaling Complex Augments L-Cell Secretion in Humans.
Sun EW; Iepsen EW; Pezos N; Lumsden AL; Martin AM; Schober G; Isaacs NJ; Rayner CK; Nguyen NQ; de Fontgalland D; Rabbitt P; Hollington P; Wattchow DA; Hansen T; Holm JC; Liou AP; Jackson VM; Torekov SS; Young RL; Keating DJ
Gastroenterology; 2021 Aug; 161(2):536-547.e2. PubMed ID: 33848536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
